Today’s Top Headlines

02 February 2024

US Equities Near Best Levels; Gold and Bitcoin Up, WTI Crude Down in Volatile Trading; NEXTracker, Corteva and Etsy Shine

New York, February 01, 2024 - PRISM MarketView - Insights from Prism MarketView: A round up of the top headlines dominating news feeds today.

Market Moves: Dow +0.97%, S&P 500 +1.25%, Nasdaq +1.30%, Russell 2000 +1.39%

US equities finished the day higher on Thursday, ending near best levels. Big tech performed better and other outperformers included fertilizers, machinery, rails, software, restaurants and homebuilders. Regional banks, insurance, managed care and steel underperformed. Treasuries were firmer, the Dollar index was down (0.2%), Gold finished up +0.2%, Bitcoin futures were up +1.3 and WTI crude settled down (2.7%) in volatile trading.

In today’s headlines, notable gainers were NEXTracker ($NXT) which was up +24.8% on strong FQ3 EPS and revenue and raising FY24 EPS and revenue guidance. The company highlighted revenue growth of 38% year over year, record backlog, and supply chain optimization, and noted that the situation in the Red Sea has impacted some costs and deliveries. Corteva ($CTVA) rose by +18.9% after beating Q4 operating EPS and revenue, and Norfolk Southern ($NSC) gained +9.1% after news that an Ancora Holdings-led group has reportedly acquired a $1 billion stake in the company. Etsy ($ETSY) was up +9.1% at the closing bell.

Top performers in the PRISM indexes were Trio Petroleum ($TPET) which surged 46.16%, Sorrento Therapeutics ($SRNEQ) which gained 27.05% and BioStem Technologies ($BSEM) which rose by 23.12% after recapping 2023’s operational and financial highlights this week. CareMax ($CMAX) fell by (34.28%), Peloton ($PTON) lost (24.28%) after announcing an FQ2 EBITDA decline larger than expected, and Vivos Therapeutics ($VVOS) lost (16.68%).

Trio Petroleum Corp. - Prism MarketView

Trio Petroleum Corp. is a California-focused oil and gas exploration and development company headquartered in Bakersfield, California, with operations in Monter

Sorrento Therapeutics, Inc. - Prism MarketView

Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to

BioStem Technologies - Prism MarketView

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercializat

CareMax, Inc. - Prism MarketView

CareMax is a Medicare Advantage organization with a full complement of health and wellness services for the senior population. CareMax plays a significant role

Peloton Interactive, Inc. - Prism MarketView

Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchsc

Vivos Therapeutics, Inc. - Prism MarketView

The Vivos® Method targets mild-to-moderate obstructive sleep apnea and dento-facial abnormalities and deficiencies. Vivos offers a multidisciplinary treatment

Today’s Headlines

It’s No Surprise, AI Continues to Dominate Tech Earnings This Season

Quick Recap: It’s No Surprise, AI Continues to Dominate Tech Earnings This Season - Prism MarketView

Leading companies in technology and related fields are reporting October-December results, providing insight on how artificial intelligence (AI) continues to im

Leading companies in technology and related fields are reporting October-December results, providing insight on how artificial intelligence (AI) continues to impact future earnings.

PRISM Healthcare Index Update: BULLFROG AI HOLDINGS Sees Stock Dip

PRISM Healthcare Index Update: BULLFROG AI HOLDINGS Sees Stock Dip - Prism MarketView

BullFrog AI Holdings (NASDAQ: BFRG), known for its innovative approach in drug development using artificial intelligence and machine learning, experienced a dec

BullFrog AI Holdings (NASDAQ: BFRG), known for its innovative approach in drug development using artificial intelligence and machine learning, experienced a decline in its stock following the announcement of its public offering.

Bullfrog AI Holdings, Inc. - Prism MarketView

BullFrog AI (NASDAQ: BFRG) is a technology-enabled life science company using advanced artificial intelligence (AI) to usher in the next generation of lifesavin

PRISM AdTech & Media Spotlight: S&P 1500 Communications Drops; Paramount Surges and Netflix Gains, Roblox Slips

PRISM AdTech & Media Spotlight: S&P 1500 Communications Drops; Paramount Surges and Netflix Gains, Roblox Slips - Prism MarketView

US equities finished the day lower Wednesday at worst levels after the Federal Open Market Committee (FOMC) meeting today left interest rates unchanged. Big tec

US equities finished the day lower Wednesday at worst levels after the Federal Open Market Committee (FOMC) meeting today left interest rates unchanged. Big tech was broadly down, led by Alphabet ($GOOGL) following lackluster earnings.

PRISM Market Momentum: Stocks on the Move on Thursday; Etsy Shines, Merck Gains, Peloton Drops on EBITDA Decline

PRISM Market Momentum: Stocks on the Move on Thursday; Etsy Shines, Merck Gains, Peloton Drops on EBITDA Decline - Prism MarketView

US equities are trading mostly higher on Thursday at midday after a lower finish on Wednesday that saw the S&P 500’s worst performance since September.

US equities are trading mostly higher on Thursday at midday after a lower finish on Wednesday that saw the S&P 500’s worst performance since September. Big tech is higher, and other outperformers include fertilizers, machinery, rails, software, apparel, and homebuilders.

NeuroBo to Initiate Clinical Trial for New Obesity Treatment

NeuroBo to Initiate Clinical Trial for New Obesity Treatment - Prism MarketView

NeuroBo Pharmaceuticals (Nasdaq: NRBO) has received FDA clearance of its Investigational New Drug (IND) application for DA-1726, a novel, dual oxyntomodulin

NeuroBo Pharmaceuticals (Nasdaq: NRBO) has received FDA clearance of its Investigational New Drug (IND) application for DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR).

Trader’s Lens

Asset Entities Inc.

Asset Entities Inc. - Prism MarketView

$ASST is leading the Prism MarketView AdTech index today. It has been trading in a range between about $0.40 and $1.00 the last couple of months.

CareMax Inc.

CareMax Inc. - Prism MarketView

$CMAX is down again today after announcing a 1-30 reverse stock split on Tuesday after the close in order to try and remain compliant with Nasdaq listing rules.